
Mr Arjun (name changed) and Ms Shilpa (name changed) are maternal cousins who were planning to get married. There was no significant clinical history suggestive of any genetic disorder in either of their families, except for a history of hypertension in their grandparents. As they are related by blood (a consanguineous union), they underwent pre-marital genetic counselling to understand the potential risk of genetic disorders in their future children.

Following counselling, both individuals opted for genetic carrier screening. The results revealed that each of them was a carrier of three deleterious mutations associated with the following autosomal recessive conditions: Primary microcephaly (CEP135 gene), Xeroderma pigmentosum (ERCC3 gene),and Reticular dysgenesis (AK2 gene).
Primary microcephaly is a condition in which the brain does not develop properly, resulting in a head size that is significantly smaller than normal.
Xeroderma pigmentosum is a genetic disorder characterised by a reduced ability to repair DNA damage. Clinical features may include extreme sensitivity to sunlight, freckles, dry skin, changes in skin pigmentation, and neurological problems such as poor coordination and loss of intellectual function.
Reticular dysgenesis is one of the rarest and most severe forms of combined immunodeficiency. It is characterised by congenital agranulocytosis, lymphopenia, and underdevelopment of lymphoid and thymic tissues, resulting in the absence of both cellular and humoral immune function.
All three conditions are severe and require long-term medical intervention, significantly impacting the quality of life of both the affected child and the family. Despite the absence of any known family history of genetic disorders, this couple was found to be at risk of having a child affected by not one, but three severe genetic conditions. Medical literature suggests that nearly 80% of couples identified as carriers have no known family history, and their carrier status often becomes evident only after the birth of an affected child.
In high-risk situations such as consanguineous marriages, counselling combined with prenatal testing can be especially beneficial, offering multiple reproductive choices and helping reduce the risk of severe genetic disorders.
MedGenome offers highly accurate non-invasive prenatal testing (NIPT), genetic carrier screening, preimplantation genetic screening/diagnosis (PGS/PGD), and product of conception (POC) testing. In addition, MedGenome provides on-demand pre- and post-test genetic counselling to support patients at every stage of their testing journey.
| MedGenome Claria Offers | Test Sample Requirements | Required Forms | TAT |
| Career screening panel package: Silver-200 genes Gold-500 genes Platinum-Over 2000 gene MLPA(SMN,DMD,CYP21A2) | ![]() | Relevant clinical information including all the clinical presentations and symptoms. | 21 to 28 days |
MedGenome offers highly accurate genetic testing services, including Non-Invasive Prenatal Testing (NIPT), Genetic Carrier Screening, Preimplantation Genetic Screening and Diagnosis (PGS/PGD), as well as Product of Conception (POC) testing. In addition, MedGenome provides on-demand genetic counselling both before and after testing for all patients.
Preimplantation Genetic Screening
Day 5 (few cells) embryon biopsy or Day3 (single cell)
Informed Consent Form & Test Requisition Form
7 working days



At MedGenome, scientific experts drive the development of innovative omics solutions that enable early detection of complex diseases. With advanced global-quality next-generation sequencing and proprietary analysis pipelines, the team consistently delivers tests and services that are transforming the way diseases are diagnosed and treated.
Sy. Nos. 94/1C and 94/2, Tower 1, Ground Floor, Veerasandra Village, Attibele Hobli, Electronic City Phase-1, Electronics City, Bangalore, Bangalore South, Karnataka, India, 560100 Toll free number: 1800 296 9696
*Explore our range of CAP-accredited tests- Click to know more